Table 1 Clinical characteristics of DLBCL patients included in ex vivo CDC assays.

From: Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL

Characteristic

No.

%

Total

20

100

Gender

 Male

7

35

 Female

9

45

 Unknown

4

20

Age

 ≤60

5

25

 >60

11

55

 Unknown

4

20

Ann Arbor stage

 I

0

0

 II

2

10

 III

7

35

 IV

3

15

 Unknown

8

40

ND/RR

 ND

15

75

 RR

5

25

Back to article page